Impact of Inflammatory Markers and Body Mass Index on TKI Toxicity in Patients With Non-Small Cell Lung Cancer Harboring an EGFR Mutation

被引：0
|
作者：
Runciman, T. [1 ]
Carracedo, C. [1 ]
Motta, R. [1 ]
Aliaga, C. [1 ]
机构：
[1] Clin Aliada, Lima, Peru
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
NLR; BMI; EGFR NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P76.12
引用
收藏
页码：S590 / S591
页数：2
相关论文
共 50 条
  • [21] Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation
    Li, Yan
    Wang, Yanmei
    Niu, Kai
    Chen, Xiewan
    Xia, Liqin
    Lu, Dingxi
    Kong, Rui
    Chen, Zhengtang
    Duan, Yuzhong
    Sun, Jianguo
    ONCOTARGET, 2016, 7 (43) : 70535 - 70545
  • [22] Survival impact of EGFR TKI on patients with lepidic brochioalveolar metastatic non-small cell lung cancer (NSCLC).
    Gagnon, Marie-Eve
    Blais, Normand
    Tehfe, Mustapha Ali
    Florescu, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] Effect of hydrothorax EGFR gene mutation and EGFR-TKI targeted therapy on advanced non-small cell lung cancer patients
    Zhou, Bo
    Nie, Jun
    Yang, Weidong
    Huang, Chenhong
    Huang, Ye
    Zhao, Hongfei
    ONCOLOGY LETTERS, 2016, 11 (02) : 1413 - 1417
  • [24] Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question
    Giuliani, Jacopo
    Martelli, Salvatore
    Remo, Andrea
    Bonetti, Andrea
    TUMORI, 2015, 101 (04) : E115 - E117
  • [25] Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation
    Chen, Yu-Mu
    Lai, Chien-Hao
    Lin, Chiung-Yu
    Tsai, Yi-Hsuan
    Chang, Ya-Chun
    Chen, Hung-Chen
    Tseng, Chia-Cheng
    Chang, Huang-Chih
    Huang, Kuo-Tung
    Chen, Yung-Che
    Fang, Wen-Feng
    Wang, Chin-Chou
    Chao, Tung-Ying
    Lin, Meng-Chih
    NUTRIENTS, 2021, 13 (11)
  • [26] Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations
    Ichihara, Eiki
    Hotta, Katsuyuki
    Takigawa, Nagio
    Kudo, Kenichiro
    Kato, Yuka
    Hondaa, Yoshihiro
    Hayakawa, Hiromi
    Minami, Daisuke
    Sato, Akiko
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    LUNG CANCER, 2013, 81 (03) : 435 - 439
  • [27] Clinical Effects of Icotinib for Brain Metastasis in Chinese Non-Small Cell Lung Cancer Patients Harboring an EGFR Mutation
    Hou, Helei
    Xu, Xiaomei
    Wang, Xiaofei
    Deng, Lihua
    Tan, Airong
    Liu, Congmin
    Yu, Wenjun
    Zhang, Chuantao
    Yan, Chun
    Cheng, Xiaofeng
    Zhang, Xiaochun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S644 - S644
  • [28] Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring EGFR Mutation
    Takamori, Shinkichi
    Toyokawa, Gouji
    Shimokawa, Mototsugu
    Kinoshita, Fumihiko
    Kozuma, Yuka
    Matsubara, Taichi
    Haratake, Naoki
    Akamine, Takaki
    Mukae, Nobutaka
    Hirai, Fumihiko
    Tagawa, Tetsuzo
    Oda, Yoshinao
    Iwaki, Toru
    Iihara, Koji
    Honda, Hiroshi
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2018, 38 (06) : 3731 - 3734
  • [29] EGFR mutation profile in Australian patients with non-small cell lung cancer
    Mead, Scott
    Lucas, Mark
    Pang, Jia-Min
    Fellowes, Andrew
    Harraway, James
    Svobodova, Suzanne
    Amanuel, Benhur
    Fox, Stephen
    PATHOLOGY, 2021, 53 (07) : 933 - 936
  • [30] Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation
    Anai, Moriyasu
    Saruwatari, Koichi
    Imamura, Kosuke
    Fujino, Kosuke
    Jodai, Takayuki
    Sakata, Shinya
    Iyama, Shinji
    Tomita, Yusuke
    Saeki, Sho
    Ichiyasu, Hidenori
    Ikeda, Koei
    Suzuki, Makoto
    Sakagami, Takuro
    JOURNAL OF THORACIC DISEASE, 2024, 16 (02) : 1151 - 1160
12345